Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Korea
Manufacturing
Korea's Celltrion throws down $330M for Lilly plant in N.J.
After teasing its position in a bidding contest for a large U.S. drug substance plant this summer, South Korea’s Celltrion has sealed the deal.
Fraiser Kansteiner
Sep 23, 2025 9:24am
Samsung Bio inks US contract manufacturing deal worth $1.3B
Sep 9, 2025 8:52am
Celltrion nears US plant purchase to offset tariff threats
Jul 30, 2025 2:56pm
Lonza posts sales rebound as Samsung Bio's growth rolls on
Jul 23, 2025 10:21am
Samsung Bio strikes $668M production tie-up with European pharma
Nov 20, 2024 2:02pm
Lotte Biologics breaks ground on $3.3B Korean production plant
Jul 8, 2024 2:55pm